Lenalidomide and Chronic Lymphocytic Leukemia

Lenalidomide is an oral immunomodulatory drug used in multiple myeloma and myelodysplastic syndrome and most recently it has shown to be effective in the treatment of various lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. The mechanism of action of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: González-Rodríguez, Ana Pilar, Payer, Angel R., Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Villa-Alvarez, Monica, Gonzalez-García, Esther, Gonzalez, Segundo
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2013
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3791640/
https://ncbi.nlm.nih.gov/pubmed/24163824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/932010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars